GPI-PLD activators belong to a distinctive chemical class renowned for their ability to modulate the activity of glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD), a crucial enzyme implicated in cellular signaling pathways. These activators exhibit a unique capacity to stimulate GPI-PLD, thereby influencing lipid metabolism and cellular processes associated with membrane dynamics. GPI-PLD, an enzyme found at the cell surface, plays a pivotal role in the cleavage of glycosylphosphatidylinositol (GPI) anchors from proteins, leading to the release of these proteins from the cell membrane. The activation of GPI-PLD by specific chemical agents has garnered attention due to its potential impact on cellular responses, including vesicular trafficking, immune system regulation, and signal transduction.
Structurally, GPI-PLD activators are characterized by their distinct chemical motifs that facilitate interaction with the catalytic domain of the GPI-PLD enzyme. These activators often feature hydrophobic and polar regions, allowing for precise engagement with the enzyme's active site and subsequent modulation of its catalytic function. The dynamic interplay between GPI-PLD activators and the enzyme underscores the intricate nature of cellular signaling regulation, as the activation of GPI-PLD initiates a cascade of events that contribute to the finely tuned balance of cellular processes. The exploration of GPI-PLD activators provides valuable insights into the fundamental mechanisms governing membrane-associated signaling, offering a foundation for further research into the broader implications of these compounds in cellular biology and molecular pharmacology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which can stimulate various signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Alters intracellular calcium levels, which can trigger multiple pathways, including those involving GPI-anchored proteins. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases the level of cyclic AMP (cAMP), a second messenger that can initiate many biological processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, a key component of many signaling pathways, potentially enhancing GPI-PLD activity indirectly. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR pathway, potentially promoting the production of GPI-anchored proteins. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits ERK, part of the MAPK pathway, potentially driving the signaling involving GPI-anchored proteins. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, part of the MAPK pathway, potentially promoting the pathways involving GPI-anchored proteins. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK3, potentially triggering GPI-PLD activation indirectly through its role in various cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially driving the signaling involving GPI-anchored proteins through its role in stress signal responses. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NFκB, a transcription factor involved in inflammation and immunity, potentially promoting the pathways involving GPI-anchored proteins. | ||||||